Investors
Tengion is privately held and is funded by the leading biotech investors listed below. To date, Tengion has raised approximately $146 million in equity capital.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Featured Information
Latest News
- May 15, 2013: Tengion Provides Business Update and Reports First Quarter 2013 Financial Results
- April 1, 2013: Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
- March 18, 2013: Tengion Provides Business Update and Reports Fourth Quarter and Full Year 2012 Financial Results
- March 12, 2013: Tengion to Present at 25th Annual ROTH Conference
- March 11, 2013: Tengion to Host Conference Call to Provide a Business Update and Report Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013